Published in F1000Prime Rep on October 01, 2014
Corticosteroid Responsive Sarcoidosis with Multisystemic Involvement Years after Initial Diagnosis: A Lymphoma Mimicker on 18-FDG PET/CT. J Clin Imaging Sci (2015) 0.78
Sarcoidosis with prevalent and severe joint localization: a case report. Multidiscip Respir Med (2016) 0.75
Sarcoidosis: a diagnostic challenge in atypical radiologic findings of unilateral lymphadenopathy. Oxf Med Case Reports (2015) 0.75
Remission of a long-lasting sarcoidosis after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. JAAD Case Rep (2016) 0.75
Trouble Spotted in the Liver! Dig Dis Sci (2016) 0.75
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med (2006) 4.20
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Preparing for precision medicine. N Engl J Med (2012) 3.34
Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis (1989) 3.08
Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics (2010) 2.32
Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest (2013) 2.21
Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1999) 2.08
A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol (2012) 2.00
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J (2008) 1.99
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab. J Cutan Pathol (2011) 1.78
The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest (2008) 1.78
Cutaneous sarcoidosis. Semin Respir Crit Care Med (2010) 1.69
Exaggerated TNFalpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2002) 1.69
Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest (1997) 1.69
Sarcoidosis-associated fatigue. Eur Respir J (2012) 1.57
The late follow-up of chronic sarcoid patients previously treated with corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.51
The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) (1999) 1.48
Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum (2003) 1.46
Treatment of sarcoidosis with infliximab. Chest (2005) 1.43
Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med (2010) 1.42
Concomitant sarcoidosis and a connective tissue disease: review of the clinical findings and postulations concerning their association. Respir Med (2013) 1.41
Immunology of sarcoidosis. Clin Chest Med (1997) 1.35
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest (2005) 1.29
Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology (2009) 1.24
Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis (2000) 1.21
A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis (1973) 1.17
Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2001) 1.16
The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis (2012) 1.15
Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med (2009) 1.15
The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum (1993) 1.15
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis (2014) 1.12
Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J (2013) 1.10
Health-related quality of life of persons with sarcoidosis. Chest (2004) 1.08
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.07
Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2012) 1.07
Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest (2003) 1.06
Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med (2010) 1.05
Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol (2007) 1.05
Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur Respir J (2003) 1.04
Prolonged use of methotrexate for sarcoidosis. Arch Intern Med (1995) 1.03
Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge. J Rheumatol (2009) 1.02
Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study. N Y State J Med (1987) 1.00
Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc (1991) 1.00
Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest (2013) 1.00
Blau syndrome, clinical and genetic aspects. Autoimmun Rev (2012) 0.99
Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Respir J (2014) 0.98
Rituximab as a treatment alternative in sarcoidosis. Joint Bone Spine (2008) 0.98
The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med (2003) 0.97
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.96
Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J (2006) 0.95
Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des Devel Ther (2013) 0.94
The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study. Ann N Y Acad Sci (1986) 0.94
A case of neurosarcoidosis successfully treated with rituximab. Neurology (2010) 0.93
Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev (2005) 0.92
Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med (2012) 0.89
Necrotizing sarcoid granulomatosis. Curr Opin Pulm Med (2012) 0.89
Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol (2010) 0.88
Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis. Respir Med (2008) 0.88
Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis. Eur Respir J (2014) 0.87
Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum (2006) 0.86
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J (2011) 0.86
Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci (2010) 0.86
The treatment of pulmonary sarcoidosis. Respir Med (2012) 0.86
Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case. Joint Bone Spine (2009) 0.86
Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis (2008) 0.84
Sarcoidosis around the world. Clin Chest Med (2008) 0.84
Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol (2003) 0.83
Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis (1997) 0.83
Granulomatous lymphocytic interstitial lung disease. Immunol Allergy Clin North Am (2012) 0.82
Acute pulmonary exacerbations of sarcoidosis. Chest (2012) 0.82
Clinical outcomes in sarcoidosis after cessation of infliximab treatment. Respirology (2009) 0.81
Sarcoidosis of the thyroid and kidneys and calcium metabolism. Semin Respir Crit Care Med (2002) 0.80
How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.78
The computed tomographic appearances in chronic berylliosis. Clin Radiol (1993) 0.78
Association between tumor necrosis factor-α (TNF-α) promoter -308 G/A and response to TNF-α blockers in rheumatoid arthritis: a meta-analysis. Mod Rheumatol (2012) 0.78
Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol (1991) 0.77
The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial. Respir Med (2013) 0.77